Alex is Co-Founder and Chief Investment Officer of Braidwell, a life science-focused investment management firm. Prior to co-founding Braidwell, Alex was a Partner, Managing Director and the Co-Portfolio Manager at Deerfield Management, from 2005 until 2021. Beyond his direct Deerfield investment activities, Alex helped conceptualize and implement the Cure, Deerfield’s healthcare innovation campus at 345 Park Avenue South. During the COVID-19 global health crisis, Alex was appointed by Governor Ned Lamont to the Reopen Connecticut Advisory Group to provide counsel on the reemergence of the state’s economy, community and education systems. He is a co-founder and board chairman of The Institute for Life Changing Medicines, a nonprofit dedicated to developing medicines for people suffering from less common, life-threatening, diseases around the world. Alex serves on the Board of the Biotechnology Innovation Organization, and previously served on the Boards of the Museum of Science, the Children’s Health Fund as Vice Chairman, New York Academy of Medicine, Discovery Labs, and Recovery Centers of America, the latter two of which he co-founded. He is also a member of the Board of the Greenwich Country Day School. Prior to Deerfield, he was a member of Merrill Lynch’s Global Equity Linked Products Group, as well as its Capital Markets team. He received a B.S. from the Massachusetts Institute of Technology and an M.S. from Johns Hopkins University.